Publications
Defining ancestry, heritability and plasticity of cellular phenotypes in somatic evolution
Schiffman JS, D’Avino AR, Prieto T, Potenski C, Fan Y, Hara T, Suvà ML, Landau DA. bioRxiv, 2022 Dec 30
A microglia-CD4+ T cell partnership generates protective anti-tumor immunity to glioblastoma
Chen D, Varanasi SK, Hara T, Traina K, McDonald B, Farsakoglu Y, Clanton J, Xu S, Mann TH, Du V, Chung HK, Xu Z, Tripple V, Casillas E, Ma S, O’Connor C, Yang Q, Zheng Y, Hunter T, Lemke G, Kaech SM. bioRxiv, 2022 Aug 14
The transcriptional hallmarks of intra-tumor heterogeneity across a thousand tumors
Gavish A, Tyler M, Simkin D, Kovarsky D, Castro LNG, Halder D, Chanoch-Myers R, Laffy J, Mints M, Greenwald AR, Wider A, Tal R, Spitzer A, Hara T, Tirosh A, Puram SV, Suva ML, Tirosh I. bioRxiv, 2021 Dec 20
Pharmacological inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic shock
Sakamoto T, Fukui Y, Kondoh Y, Honda K, Shimizu T, Hara T, Hayashi T, Saitoh Y, Murakami Y, Inoue JI, Kaneko S, Osada H, Seiki M. Commun. Biol., 2021 Oct 7;4(1):1165
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
Hara T*, Chanoch-Myers R*, Mathewson ND, Myskiw C, Atta L, Bussema L, Eichhorn SW, Greenwald AC, Kinker GS, Rodman C, Castro LNG, Wakimoto H, Rozenblatt-Rosen O, Zhuang X, Fan J, Hunter T, Verma IM, Wucherpfennig KW, Regev A, Suvà ML, Tirosh I. Cancer Cell, 2021 June 14; 39(6):779-792.e11, *co-first author
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Mathewson ND, Ashenberg O, Tirosh I, Gritsch S, Perez EM, Marx S, Jerby-Arnon L, Chanoch-Myers R, Hara T, Richman AR, Ito Y, Pyrdol J, Friedrich M, Schumann K, Poitras MJ, Gokhale PC, Castro LNG, Shore ME, Hebert CM, Shaw B, Cahill HL, Drummond M, Zhang W, Olawoyin O, Wakimoto H, Rozenblatt-Rosen O, Brastianos PK, Liu XS, Jones PS, Cahill DP, Frosch MP, Louis DN, Freeman GJ, Ligon KL, Marson A, Chiocca EA, Reardon DA, Regev A , Suvà ML, Wucherpfennig KW. Cell, 2021 Mar 4;184(5):1281-1298.e26
An integrative model of cellular states, plasticity and genetics for glioblastoma
Neftel C*, Laffy J*, Filbin MG*, Hara T*, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez L, Castro NG, Lan X, Druck N, Rodman C, Dionne D, Kaplan A, Bertalan MS, Small J, Pelton K, Becker S, Bonal D, Nguyen QD, Servis RL, Fung JM, Mylvaganam R, Mayr L, Gojo J, Haberler C, Geyeregger R, Czech T, Slavc I, Nahed BV, Curry WT, Carter BS, Wakimoto H, Brastianos PK, Batchelor TT, Stemmer-Rachamimov A, Martinez-Lage M, Frosch MP, Stamenkovic I, Riggi N, Rheinbay E, Monje M, Rozenblatt-Rosen O, Cahill DP, Patel AP, Hunter T, Verma IM, Ligon KL, Louis DN, Regev A, Bernstein BE, Tirosh I, Suvà ML. Cell, 2019 Aug 8;178(4):835-849.e21, *co-first authors
Modeling Gliomas Using Two Recombinases
Hara T#, Verma IM. Cancer Res., 2019 Aug 1;79(15):3983-3991, #corresponding author
Heterochromatin-encoded Satellite RNAs Induce Breast Cancer via De-stabilizing DNA Replication Forks
Zhu Q, Hoong N, Aslanian A, Hara T, Benner C, Heinz S, Miga KH, Ke E, Verma S, Soroczynski J, Yates JR III, Hunter T, Verma IM. Mol. Cell, 2018 Jun 7;70(5):842-853.e7
Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice
Hara T, Murakami Y, Seiki M, Sakamoto T. Biochem Biophys Res Commun., 2017 Aug 26;490(3):688-692
Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes
Hara T, Nakaoka HJ, Hayashi T, Mimura K, Hoshino D, Inoue M, Nagamura F, Murakami Y, Seiki M, Sakamoto T. Proc. Natl. Acad. Sci. USA, 2017 May 30;114(22):E4416-E4424
Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth
Nakaoka HJ, Tanei Z, Hara T, Weng JS, Kanamori A, Hayashi T, Sato H, Orimo A, Otsuji K, Tada K, Morikawa T, Sasaki T, Fukayama M, Seiki M, Murakami Y, Sakamoto T. Oncogenesis, 2017 May 15;6(5):e334
Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus
Uematsu T, Fujita T, Nakaoka HJ, Hara T, Kobayashi N, Murakami Y, Seiki M, Sakamoto T. Sci. Rep., 2016 Nov 24;6:37815
The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux
Yoshino S, Hara T, Nakaoka HJ, Kanamori A, Murakami Y, Seiki M, Sakamoto T. Cell Discov., 2016 Jul 26;2:16019
NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells
Nakaoka HJ, Hara T, Yoshino S, Kanamori A, Matsui Y, Shimamura T, Sato H, Murakami Y, Seiki M, Sakamoto T. Sci. Rep., 2016 Mar 7;6:2278
Hypoxia-inducible factor 1 regulation through cross talk between mTOR and MT1-MMP
Sakamoto T, Weng JS, Hara T, Yoshino S, Kozuka-Hata H, Oyama M, Seiki M. Mol. Cell Biol., 2014 Jan;34(1):30-42
Genetic screening of new genes responsible for cellular adaptation to hypoxia using a genome-wide shRNA library
Yoshino S, Hara T, Weng JS, Takahashi Y, Seiki M, and Sakamoto T. PLoS ONE, 2012. April 16;7(4). e35590
Genetic dissection of proteolytic and non-proteolytic contributions of MT1-MMP to macrophage invasion
Hara T, Mimura K, Seiki M, Sakamoto T. Biochem. Biophys. Res. Commun., 2011 Sep 23;413(2):277-81
Deletion of the Mint3/APBA3 gene in mice abrogates macrophage functions and increases resistance to lipopolysaccharide-induced septic shock
Hara T, Mimura K, Abe T, Shioi G, Seiki M, Sakamoto T. J. Biol. Chem., 2011 Sep 16;286(37):32542-51